Revision history of "Ofatumumab servicing versus statement in relapsed longterm lymphocytic leukaemia PROLONG the openlabel multicentre randomised stage Several research"

From EECH Central
Jump to: navigation, search

Diff selection: Mark the radio boxes of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

  • (cur | prev) 11:00, 17 May 2024‎ Waterotter77 (Talk | contribs)‎ . . (3,729 bytes) (+3,729)‎ . . (Created page with "Sorafenib added to gemcitabine did none increase RFS nor Operating system. Nonetheless, postoperative remedy going above half a year seemed to lengthen survival and should be...")
Retrieved from "http://eechcentral.simhq.com/index.php?title=Ofatumumab_servicing_versus_statement_in_relapsed_longterm_lymphocytic_leukaemia_PROLONG_the_openlabel_multicentre_randomised_stage_Several_research"